Business

Granules India gets USFDA nod for sleep aid drug

Drug firm Granules India on Friday said it has received the US health regulator's approval for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, used for relief in occasional sleeplessness associated with minor aches and pains. The approved product is the generic equivalent of Aleve PM tablets of Bayer HealthCare LLC.

migrator

New Delhi

The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC), Granules said in a BSE filing. Granules now has a total of 31 ANDA approvals from the USFDA (29 Final approvals and 2 tentative approvals).

Shares of Granules India were trading 3.33 per cent higher at Rs 372.60 apiece on BSE.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Also Read

PMK removes Anbumani Ramadoss from party, reinstates Dr Ramadoss as party leader

Unnao rape case: SC stays Delhi HC order suspending Sengar's life sentence

TN under grip of alcohol, violent crimes against women are on the rise: TN BJP

Indonesia: 16 killed in nursing home fire in Manado; victim identification underway

Delhi: Congress workers protest outside SC, demanding justice for Unnao rape survivor